Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
23.16
-0.43 (-1.82%)
At close: Nov 20, 2026, 4:00 PM EST
23.16
0.00 (0.00%)
After-hours: Nov 20, 2026, 7:30 PM EST
Rapport Therapeutics Market Cap
Rapport Therapeutics has a market cap or net worth of $1.37 billion as of November 20, 2026. It is the 7,908th most valuable company in the world and the 1,952nd biggest in the United States. Its market cap has increased by 7.16% in one year.
Market Cap
1.37B
Enterprise Value
987.28M
1-Year Change
7.16%
Global Rank
Country Rank
#1,952 United States
Category
ChartMarket Cap Chart
Since the IPO on June 7, 2024, Rapport Therapeutics's market cap has increased from $601.40M to $1.37B, an increase of 128.29%. That is a compound annual growth rate of 39.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 1.37B | -5.06% |
| Dec 31, 2025 | 1.45B | 122.86% |
| Dec 31, 2024 | 648.87M | 7.89% |
| Jun 7, 2024 (IPO) | 601.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Intellia Therapeutics | 1.44B |
| Immunocore Holdings | 1.44B |
| Damora Therapeutics | 1.41B |
| UroGen Pharma | 1.41B |
| Nuvation Bio | 1.40B |
| Nanobiotix | 1.39B |
| Tyra Biosciences | 1.38B |
| Ocular Therapeutix | 1.36B |